About The Task Force
The GVN Chikungunya Task Force is a group of leading scientists from around the world committed to finding solutions to the growing problem of Chikungunya virus.
What is Chikungunya?
- Chikungunya is a mosquito-borne viral disease that causes its victims to suffer severe fever and debilitating pain.
- There is no specific antiviral drug treatment or vaccine for Chikungunya; treatment is directed primarily at relieving the symptoms.
- Chikungunya was first described during an outbreak in Tanzania in 1952, but has most recently reached the Caribbean and South America – and is predicted to soon cause outbreaks in the United States.
What will the Task Force do?
- Review the state of the science and potential research opportunities on animal models of infection and disease, candidate vaccine constructs, new anti-viral drugs, and seroepidemiology studies for previously unrecognized cases of CHIK, while including a focus on the Caribbean.
- Identify potential funding sources to support international collaborative research and address gaps in knowledge.
- Train the next generation of researchers to study the interactions between viruses and mosquito vectors.
- Provide expertise and visibility as GVN speaks about this challenge to a variety of audiences.